WHO ICTRP trial
Effect of platelet-rich plasma on chronic endometritis
IRCT20240917063075N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20240917063075N1 |
|---|---|
| Public title | Effect of platelet-rich plasma on chronic endometritis |
| Scientific title | Evaluation of the effect of platelet-rich plasma on chronic endometritis in patients with recurrent implantation failure |
| Primary sponsor | Shahre-kord University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Chronic endometritis. Chronic inflammatory disease of uterus;N71.1 |
| Interventions | Intervention group: Women with chronic endometritis with repeated implantation failure. |
| Registration date | Oct 28, 2024 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: